Stereotaxis to Announce Third Quarter Financial Results
ST. LOUIS, October 23, 2024 - Stereotaxis (NYSE: STXS), renowned for its pioneering advancements in surgical robotics, is set to unveil its financial results for the third quarter of 2024. This important announcement will be made public on a pivotal day for the financial markets, specifically targeting November 11, 2024.
Details of the Financial Results Call
On that day, Stereotaxis will host a critical conference call and webcast starting at 4:30 p.m. ET. This event offers a unique opportunity for stakeholders, analysts, and interested parties to hear directly from the company's leadership about its financial performance and significant developments during the quarter.
How to Participate in the Call
For those interested in joining the call, there are multiple ways to do so. Participants in the United States and Canada can dial 800-715-9871, while international participants can reach the call at 1-646-307-1963. When connecting, attendees will need to provide the participant pass code: 7792742.
Accessing Webcast and Replay Options
A webcast of the call will be available, allowing participants to join the discussion from anywhere. Attendees can find the live and replay options on the investor relations section of the Stereotaxis website. This ensures that even those who cannot attend the live event will have access to the information shared.
About Stereotaxis
Stereotaxis remains at the forefront of innovation in surgical robotics, delivering cutting-edge solutions for minimally invasive endovascular interventions. The organization is dedicated to creating robotic systems and instruments that prioritize patient safety and enhance procedural efficiency. The technology developed by Stereotaxis has successfully impacted the lives of over 150,000 patients globally, reflecting its commitment to advancing healthcare.
Company’s Impact on Medical Innovations
With its state-of-the-art solutions, Stereotaxis continues to redefine the capabilities of interventional laboratories. The mission revolves around not only improving patient outcomes but also expanding access to innovative therapies. Furthermore, these cutting-edge technologies augment the overall functionality of the operating room, ensuring increased productivity and connectivity.
Contact Information for Investors
For investor inquiries, Stereotaxis has made it easy to connect with its executive team. David L. Fischel, Chairman, and Chief Executive Officer, as well as Kimberly Peery, Chief Financial Officer, are readily available to address any questions or concerns regarding the company’s performance. Interested parties can reach the company at 314-678-6100 or via email at Investors@Stereotaxis.com.
Frequently Asked Questions
When will Stereotaxis release its third quarter financial results?
Stereotaxis is set to disclose its third quarter financial results on November 11, 2024, after the U.S. financial markets close.
How can I participate in the conference call?
You can participate by dialing 800-715-9871 for U.S. and Canada calls, or 1-646-307-1963 for international calls, using the pass code 7792742.
Will there be a webcast available for the financial results call?
Yes, Stereotaxis will offer a live webcast of the conference call, and a replay will also be made available for those who cannot attend live.
What is Stereotaxis known for?
Stereotaxis is known for its innovative surgical robotics technology used in minimally invasive endovascular interventions, which enhances safety and efficiency in medical procedures.
How can I contact Stereotaxis for investor-related queries?
For investor inquiries, you can reach David L. Fischel or Kimberly Peery at 314-678-6100 or email Investors@Stereotaxis.com.
